Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04765319 · ClinicalTrials.gov registry record
Delivery Considerations of Cognitive Processing Therapy for PTSD
A clinical trial, sponsored by VA Salt Lake City Health Care System.
- Completed
- Registry status
- 64
- Enrollment target
NCT04765319: Completed study, sponsored by VA Salt Lake City Health Care System.
NCT04765319 is a clinical trial that has completed, run by VA Salt Lake City Health Care System. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04765319 has completed, sponsored by VA Salt Lake City Health Care System.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
Review treatment outcomes of modifications to standard delivery of CPT for PTSD that are delivered as routine care at in VA outpatient clinic.
Primary Outcome
Self report PTSD symptom inventory
Interventions
- BEHAVIORAL CPT for PTSD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2025-03-24 |
What the finished NCT04765319 record still lists
NCT04765319 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CPT for PTSD is the first listed.
NCT04765319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04765319 about?
NCT04765319 is a clinical study titled "Delivery Considerations of Cognitive Processing Therapy for PTSD". Review treatment outcomes of modifications to standard delivery of CPT for PTSD that are delivered as routine care at in VA outpatient clinic.
What is the current status of trial NCT04765319?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2016-01-01. Estimated completion is 2025-03-24.
What interventions are being tested in trial NCT04765319?
The interventions under investigation include: CPT for PTSD (BEHAVIORAL).
Who is sponsoring clinical trial NCT04765319?
This trial is sponsored by VA Salt Lake City Health Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI